ENDRA Life Sciences Inc (NDRA NASDAQ) stock market data APIs
$4.6567
0.03(0.6%)
as of April 2, 2026
Try our APIs with
free plan!
ENDRA Life Sciences Inc Financial Data Overview
Price chart is built with
Anychart
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Prev. Close
4.6567
Open
4.6767
High
4.7252
Low
4.339
52 wk Range
2.9-11.96
Market Cap
7 021 K
Shares Outstanding
1 497 K
EPS
-2.2347
Beta
-0.112
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ENDRA Life Sciences Inc data using free add-ons & libraries
Get ENDRA Life Sciences Inc Fundamental Data
ENDRA Life Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -5 719 056
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-31
- EPS/Forecast: -1.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ENDRA Life Sciences Inc News
New
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator r...
ENDRA's TAEUS Liver Device Shows Strong Consistency In Clinical Study; Stock Up
(RTTNews) - ENDRA Life Sciences Inc. (NDRA) has reported encouraging results from a clinical study evaluating the consistency of its TAEUS Liver device, a technology designed to measure liver fat at t...
Endra Life Sciences GAAP EPS of -$2.10 misses by $0.15
* Endra Life Sciences press release [https://seekingalpha.com/pr/20309530-endra-life-sciences-recaps-major-milestones-and-new-strategic-initiatives-announces-third] (NDRA [https://seekingalpha.com/s...
Endra Life Sciences commences staking of HYPE digital asset holdings
ENDRA Life Sciences (NDRA) announced it has commenced staking its holdings of HYPE (HYPE-USD), the native token of the Hyperliquid ecosystem. The company said the move is designed to maximize the util...
Get ENDRA Life Sciences Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
